Symbol not found

:ALNA   00:00AM GMT
0.00
0.00 (0.00%)
Debt Financing / Related, Bankruptcy / Related

Allena Pharmaceuticals Inc - Filed A Voluntary Petition For Relief Under The Provisions Of Chapter 11 Of Title 11 Of The United States Code

Published: 09/02/2022 21:35 GMT
(ALNA) - Allena Pharmaceuticals Inc - Filed a Voluntary Petition for Relief Under the Provisions of Chapter 11 of Title 11 of the United States Code.
Allena Pharmaceuticals Inc - Has Appointed Matthew Foster As the Company’s Chief Restructuring Officer, Effective As of September 2, 2022.
Allena Pharmaceuticals- Terminated Employment of Substantially All of Its Employees, Including Louis Brenner, President and CEO and Richard Katz, Cfo.
Allena Pharmaceuticals- Intends to Continue to Operate Its Business at Reduced Level As a “debtor-in-possession” Under the Jurisdiction of Court.
Further Company Coverage: Alnao ((reuters.
Briefs@thomsonreuters.
Com;)).